Li Qiao
- Molecular Biology top 10%
- Cancer Research top 5%
- Biomedical Engineering top 10%
- Surgery top 10%
- Biomaterials top 5%
- Topics
- MicroRNA in disease regulation (7 papers)Cancer-related molecular mechanisms research (7 papers)Extracellular vesicles in disease (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Qiao
39 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 913
- Cancer Research 471
- Biomedical Engineering 330
- Surgery 320
- Biomaterials 274
Countries citing papers authored by Li Qiao
This map shows the geographic impact of Li Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Qiao more than expected).
Fields of papers citing papers by Li Qiao
This network shows the impact of papers produced by Li Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Qiao. The network helps show where Li Qiao may publish in the future.
Co-authorship network of co-authors of Li Qiao
This figure shows the co-authorship network connecting the top 25 collaborators of Li Qiao. A scholar is included among the top collaborators of Li Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Qiao. Li Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 26 | |
| 6 | Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugsbreakdown → | 325 |
| 7 | 14 | |
| 8 | 229 | |
| 9 | 44 | |
| 10 | 249 | |
| 11 | 12 | |
| 12 | 14 | |
| 13 | 4 | |
| 14 | 4 | |
| 15 | 84 | |
| 16 | 24 | |
| 17 | 4 | |
| 18 | 2 | |
| 19 | 8 | |
| 20 | Activation of Pparγ and Inhibition of Xiap in Human Cancer Cells: Synergistic Effects On Cell Proliferation, Apoptosis, and Tumorigenesis | 1 |
About Li Qiao
Li Qiao is a scholar working on Cancer Research, Developmental Neuroscience and Aging, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Cancer Research (471 citations), Biomaterials (274 citations) and Pharmaceutical Science (103 citations). Li Qiao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Teng Su, Ke Huang, Ke Cheng, Shiqi Hu, Zhenhua Li, Junnan Tang, Jhon Cores, Tyler A. Allen, Phuong‐Uyen Dinh and Adam C. Vandergriff. Their work appears in journals such as Journal of Clinical Investigation, ACS Nano and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.